Description
Vidalista (Tadalafil) 5 mg
Vidalista 5 mg is identified here as a tadalafil product. Tadalafil is a prescription phosphodiesterase type 5 (PDE5) inhibitor used in men with erectile dysfunction and, in some approved products, for benign prostatic hyperplasia-related lower urinary tract symptoms. Product-specific approval and naming should be confirmed against the local prescribing information.
Active Ingredient and Medicine Class
The verified active ingredient is tadalafil, a PDE5 inhibitor. This class enhances nitric oxide–mediated smooth muscle relaxation and increases blood flow in erectile tissue.
Established Medical Uses
Tadalafil is established for the treatment of erectile dysfunction. Some regulatory labels also include use for lower urinary tract symptoms associated with benign prostatic hyperplasia, and the 5 mg strength has been studied for once-daily use in this setting.
How It Works
Tadalafil inhibits PDE5, an enzyme that breaks down cyclic guanosine monophosphate. By slowing this breakdown, it supports the smooth muscle relaxation needed for an erection in response to sexual stimulation.
Important Safety Information
Tadalafil must not be used with nitrates because the combination can cause a dangerous fall in blood pressure. It is also contraindicated with guanylate cyclase stimulators such as riociguat. Caution is required with alpha-blockers, antihypertensive medicines, potent CYP3A4 inhibitors, and substantial alcohol intake because these can increase blood-pressure-related effects or tadalafil exposure. Patients with cardiovascular disease may need special assessment because sexual activity itself can pose risk.
Important rare warnings include prolonged erection or priapism, sudden vision loss related to non-arteritic anterior ischemic optic neuropathy, and sudden hearing loss.
Possible Side Effects
Common adverse effects reported with tadalafil include headache, dyspepsia, back pain, myalgia, nasal congestion, and flushing. More serious reactions are uncommon but can include priapism and sudden visual or hearing disturbances.
Scientific Evidence
Clinical reviews and randomized-trial evidence support tadalafil as an effective PDE5 inhibitor for erectile dysfunction, including once-daily 5 mg use. A meta-analysis of six randomized controlled trials found improved erectile-function outcomes with tadalafil 5 mg daily versus placebo, with acceptable tolerability.
Medical Information Notice
This page is an educational summary based on sources available at the time of review and does not replace the official patient leaflet or assessment by a qualified healthcare professional.
Medical Sources
- FDA — CIALIS (tadalafil) tablets, for oral use
- Jiajia Ma et al. — Role of application of tadalafil 5 mg once-daily (≥6 months) in men with erectile dysfunction from six randomized controlled trials — Translational Andrology and Urology, 2020
